Effect of titanium dioxide nanoparticles on the cardiovascular system after oral administration

Toxicology Letters

Volumn 239, Issue 2, 2015, Pages 123-130

  Chen, Zhangjian ^a   Wang, Yun ^a   Zhuo, Lin ^a   Chen, Shi ^a   Zhao, Lin ^a   Luan, Xianguo ^a   Wang, Haifang ^b   Jia, Guang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b SHANGHAI UNIVERSITY   (China)

Author keywords

Cardiac damage; Cardiovascular effect; Inflammatory response; Oral administration; Titanium dioxide nanoparticles

Indexed keywords

2 HYDROXYBUTYRATE DEHYDROGENASE; CREATINE KINASE; INTERLEUKIN 6; LACTATE DEHYDROGENASE; NANOPARTICLE; TITANIUM DIOXIDE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; METAL NANOPARTICLE; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR SYSTEM; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; GRANULOCYTE; HEART FUNCTION; HEART INJURY; HEART RATE; HISTOPATHOLOGY; LEUKOCYTE COUNT; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTOLIC BLOOD PRESSURE; ANIMAL; BLOOD PRESSURE; CHEMICALLY INDUCED; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEART DISEASE; MALE; METABOLISM; ORAL DRUG ADMINISTRATION; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; BLOOD PRESSURE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; HEART DISEASES; HEART RATE; MALE; METAL NANOPARTICLES; RATS; RATS, SPRAGUE-DAWLEY; TITANIUM;

EID: 84942509256     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2015.09.013     Document Type: Article

References (40)

1. Blank F., Stumbles P.A., Seydoux E., Holt P.G., Fink A., Rothen-Rutishauser B., Strickland D.H., von Garnier C. Size-dependent uptake of particles by pulmonary antigen-presenting cell populations and trafficking to regional lymph nodes. Am. J. Respir. Cell Mol. Biol. 2013, 49:67-77.
2. Bouwmeester H., Dekkers S., Noordam M.Y., Hagens W.I., Bulder A.S., de Heer C., ten Voorde S.E., Wijnhoven S.W., Marvin H.J., Sips A.J. Review of health safety aspects of nanotechnologies in food production. Regul. Toxicol. Pharm. 2009, 53:52-62.
3. Bu Q., Yan G., Deng P., Peng F., Lin H., Xu Y., Cao Z., Zhou T., Xue A., Wang Y., Cen X., Zhao Y.L. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration. Nanotechnology 2010, 21:125105.
4. Chen H., Seiber J.N., Hotze M. ACS select on nanotechnology in food and agriculture: a perspective on implications and applications. J. Agric. Food Chem. 2014, 62:1209-1212.
5. Chen T., Hu J., Chen C., Pu J., Cui X., Jia G. Cardiovascular effects of pulmonary exposure to titanium dioxide nanoparticles in ApoE knockout mice. J. Nanosci. Nanotechnol. 2013, 13:3214-3222.
6. Chen Z., Wang Y., Zhuo L., Chen S., Zhao L., Chen T., Li Y., Zhang W., Gao X., Li P., Wang H., Jia G. Interaction of titanium dioxide nanoparticles with glucose on young rats after oral administration. Nanomedicine 2015, 11:1633-1642.
7. Cui Y., Gong X., Duan Y., Li N., Hu R., Liu H., Hong M., Zhou M., Wang L., Wang H., Hong F. Hepatocyte apoptosis and its molecular mechanisms in mice caused by titanium dioxide nanoparticles. J. Hazard. Mater. 2010, 183:874-880.
8. 2 nanoparticles. J. Biomed. Mater. Res. A 2011, 96:221-229.
9. Danesh J., Kaptoge S., Mann A.G., Sarwar N., Wood A., Angleman S.B., Wensley F., Higgins J.P., Lennon L., Eiriksdottir G., Rumley A., Whincup P.H., Lowe G.D., Gudnason V. Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review. PLoS Med. 2008, 5:e78.
10. Djordjevich D.M., De Luka S.R., Milovanovich I.D., Jankovic S., Stefanovic S., Veskovic-Moracanin S., Cirkovic S., Ilic A.Z., Ristic-Djurovic J.L., Trbovich A.M. Hematological parameters' changes in mice subchronically exposed to static magnetic fields of different orientations. Ecotoxicol. Environ. Saf. 2012, 81:98-105.
11. Du Z., Zhao D., Jing L., Cui G., Jin M., Li Y., Liu X., Liu Y., Du H., Guo C., Zhou X., Sun Z. Cardiovascular toxicity of different sizes amorphous silica nanoparticles in rats after intratracheal instillation. Cardiovasc. Toxicol. 2013, 13:194-207.
12. Duan J., Yu Y., Li Y., Yu Y., Sun Z. Cardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish model. Biomaterials 2013, 34:5853-5862.
13. Duan Y., Liu J., Ma L., Li N., Liu H., Wang J., Zheng L., Liu C., Wang X., Zhao X., Yan J., Wang S., Wang H., Zhang X., Hong F. Toxicological characteristics of nanoparticulate anatase titanium dioxide in mice. Biomaterials 2010, 31:894-899.
14. Gui S., Zhang Z., Zheng L., Cui Y., Liu X., Li N., Sang X., Sun Q., Gao G., Cheng Z., Cheng J., Wang L., Tang M., Hong F. Molecular mechanism of kidney injury of mice caused by exposure to titanium dioxide nanoparticles. J. Hazard. Mater. 2011, 195:365-370.
15. Hendren C.O., Mesnard X., Droge J., Wiesner M.R. Estimating production data for five engineered nanomaterials as a basis for exposure assessment. Environ. Sci. Technol. 2011, 45:2562-2569.
16. Jia X., Guo X., Li H., An X., Zhao Y. Characteristics and popular topics of latest researches into the effects of air particulate matter on cardiovascular system by bibliometric analysis. Inhal. Toxicol. 2013, 25:211-218.
17. Johnston H., Pojana G., Zuin S., Jacobsen N.R., Moller P., Loft S., Semmler-Behnke M., McGuiness C., Balharry D., Marcomini A., Wallin H., Kreyling W., Donaldson K., Tran L., Stone V. Engineered nanomaterial risk. Lessons learnt from completed nanotoxicology studies: potential solutions to current and future challenges. Crit. Rev. Toxicol. 2013, 43:1-20.
18. Kan H., Wu Z., Lin Y.C., Chen T.H., Cumpston J.L., Kashon M.L., Leonard S., Munson A.E., Castranova V. The role of nodose ganglia in the regulation of cardiovascular function following pulmonary exposure to ultrafine titanium dioxide. Nanotoxicology 2014, 8:447-454.
19. Kaptoge S., Seshasai S.R., Gao P., Freitag D.F., Butterworth A.S., Borglykke A., Di Angelantonio E., Gudnason V., Rumley A., Lowe G.D., Jorgensen T., Danesh J. Inflammatory cytokines and risk of coronary heart disease: new prospective study and updated meta-analysis. Eur. Heart J. 2014, 35:578-589.
20. Karottki D.G., Beko G., Clausen G., Madsen A.M., Andersen Z.J., Massling A., Ketzel M., Ellermann T., Lund R., Sigsgaard T., Moller P., Loft S. Cardiovascular and lung function in relation to outdoor and indoor exposure to fine and ultrafine particulate matter in middle-aged subjects. Environ. Int. 2014, 73:372-381.
21. McKinney W., Jackson M., Sager T.M., Reynolds J.S., Chen B.T., Afshari A., Krajnak K., Waugh S., Johnson C., Mercer R.R., Frazer D.G., Thomas T.A., Castranova V. Pulmonary and cardiovascular responses of rats to inhalation of a commercial antimicrobial spray containing titanium dioxide nanoparticles. Inhal. Toxicol. 2012, 24:447-457.
22. Nelin T.D., Joseph A.M., Gorr M.W., Wold L.E. Direct and indirect effects of particulate matter on the cardiovascular system. Toxicol. Lett. 2012, 208:293-299.
23. Nogueira C.M., de Azevedo W.M., Dagli M.L., Toma S.H., Leite A.Z., Lordello M.L., Nishitokukado I., Ortiz-Agostinho C.L., Duarte M.I., Ferreira M.A., Sipahi A.M. Titanium dioxide induced inflammation in the small intestine. World J. Gastroenterol. 2012, 18:4729-4735.
24. Oberdorster G. Pulmonary effects of inhaled ultrafine particles. Int. Arch. Occup. Environ. Health 2001, 74:1-8.
25. Oberdorster G. Safety assessment for nanotechnology and nanomedicine: concepts of nanotoxicology. J. Intern. Med. 2010, 267:89-105.
26. Oberdorster G., Oberdorster E., Oberdorster J. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ. Health Perspect. 2005, 113:823-839.
27. Polichetti G., Cocco S., Spinali A., Trimarco V., Nunziata A. Effects of particulate matter (PM(10): PM(2.5) and PM(1)) on the cardiovascular system. Toxicology 2009, 261:1-8.
28. 2 production as a basis for exposure assessment. Environ. Sci. Technol. 2009, 43:4227-4233.
29. Sager T.M., Kommineni C., Castranova V. Pulmonary response to intratracheal instillation of ultrafine versus fine titanium dioxide: role of particle surface area. Part. Fibre Toxicol. 2008, 5:17.
30. Savi M., Rossi S., Bocchi L., Gennaccaro L., Cacciani F., Perotti A., Amidani D., Alinovi R., Goldoni M., Aliatis I., Lottici P.P., Bersani D., Campanini M., Pinelli S., Petyx M., Frati C., Gervasi A., Urbanek K., Quaini F., Buschini A., Stilli D., Rivetti C., Macchi E., Mutti A., Miragoli M., Zaniboni M. Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue. Part. Fibre Toxicol. 2014, 11:63.
31. Savolainen K., Alenius H., Norppa H., Pylkkanen L., Tuomi T., Kasper G. Risk assessment of engineered nanomaterials and nanotechnologies-a review. Toxicology 2010, 269:92-104.
32. Simeonova P.P., Erdely A. Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers. Inhal. Toxicol. 2009, 21(Suppl. 1):68-73.
33. Smith S.C., Chen D., Collins A., Harold J.G., Jessup M., Josephson S., Logstrup S., Jur C., Sacco R.L., Vardas P.E., Wood D.A., Zoghbi W.A. Moving from political declaration to action on reducing the global burden of cardiovascular diseases: a statement from the global cardiovascular disease taskforce. Circulation 2013, 128:2546-2548.
34. Trouiller B., Reliene R., Westbrook A., Solaimani P., Schiestl R.H. Titanium dioxide nanoparticles induce DNA damage and genetic instability in vivo in mice. Cancer Res. 2009, 69:8784-8789.
35. Wang J., Zhou G., Chen C., Yu H., Wang T., Ma Y., Jia G., Gao Y., Li B., Sun J., Li Y., Jiao F., Zhao Y., Chai Z. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. Toxicol. Lett. 2007, 168:176-185.
36. Wang Y., Chen Z., Ba T., Pu J., Chen T., Song Y., Gu Y., Qian Q., Xu Y., Xiang K., Wang H., Jia G. Susceptibility of young and adult rats to the oral toxicity of titanium dioxide nanoparticles. Small 2013, 9:1742-1752.
37. Weichenthal S., Villeneuve P.J., Burnett R.T., van Donkelaar A., Martin R.V., Jones R.R., DellaValle C.T., Sandler D.P., Ward M.H., Hoppin J.A. Long-term exposure to fine particulate matter: association with nonaccidental and cardiovascular mortality in the agricultural health study cohort. Environ. Health Perspect. 2014, 122:609-615.
38. Weir A., Westerhoff P., Fabricius L., Hristovski K., von Goetz N. Titanium dioxide nanoparticles in food and personal care products. Environ. Sci. Technol. 2012, 46:2242-2250.
39. Yang J., Mou Y., Wu T., Ye Y., Jiang J.C., Zhao C.Z., Zhu H.H., Du C.Q., Zhou L., Hu S.J. Cardiac-specific overexpression of farnesyl pyrophosphate synthase induces cardiac hypertrophy and dysfunction in mice. Cardiovasc. Res. 2013, 97:490-499.
40. Yang Y., Doudrick K., Bi X., Hristovski K., Herckes P., Westerhoff P., Kaegi R. Characterization of food-grade titanium dioxide: the presence of nanosized particles. Environ. Sci. Technol. 2014, 48:6391-6400.